What a circus… and for no reason.
Personally I’m invested to see the company develop at least one new patented drug. That won’t happen in January or February but the benchmark is GW Pharma, acquired for US $7.4 billion with one CBD based drug.
OSA could well be the first successful drug for IHL and it’s a multi billion dollar opportunity. Remember it’s the clinical programs that are driving shareholder value.
Achieving a US listing will expose the company to a more sophisticated market but it hardly matters if it happens this week. Some of the comments on this thread are so short sighted.
- Forums
- ASX - By Stock
- Ann: Update on Nasdaq Listing
What a circus… and for no reason. Personally I’m invested to see...
-
-
- There are more pages in this discussion • 495 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online